Renaissance Technologies’s Ambrx Biopharma Inc AMAM Stock Holding History

Renaissance Technologies’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-53,900	Closed	-$768K	–	4201
2023 Q4	$768K	Buy	+53,900	New	+$612K	﹤0.01%	2562
2023 Q1	–	Sell	-32,500	Closed	-$74K	–	4499
2022 Q4	$74K	Sell	32,500 -31,500	-49%	-$36K	﹤0.01%	3706
2022 Q3	$69K	Buy	64,000 +53,000	+482%	+$109K	﹤0.01%	3685
2022 Q2	$29K	Sell	11,000 -11,600	-51%	-$44.2K	﹤0.01%	4084
2022 Q1	$93K	Buy	22,600 +10,800	+92%	+$55.2K	﹤0.01%	3808
2021 Q4	$107K	Buy	+11,800	New	+$132K	﹤0.01%	3669

Renaissance Technologies's AMAM Position: Q1 2024 in Review

Renaissance Technologies sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 53,900 shares — an estimated $768K sold.

Renaissance Technologies first reported a position in AMAM in Q4 2021 and held it in 6 quarters. The position peaked at $768K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Renaissance Technologies reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Renaissance Technologies sold 53,900 Ambrx Biopharma Inc shares in Q1 2024, an estimated $768K.
Renaissance Technologies first reported a position in Ambrx Biopharma Inc in Q4 2021 and held it in 6 quarters.
Renaissance Technologies's Ambrx Biopharma Inc position peaked at $768K in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.